abstract |
The present invention relates to compounds of formula (I), wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y adopt any of the values defined in the description, and associated pharmaceutically acceptable salts, which are useful as agents in the treatment of diseases and conditions, including cancer. The present invention further relates to pharmaceutical compositions comprising compounds of formula (I). |